FILE:WFC/WFC-8K-20100913105134.txt.gz
EVENTS:	Financial Statements and Exhibits
TEXT:
ITEM: Financial Statements and Exhibits
 
 
 
 
 
 
 
 
 
 
 
 
 
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
 
 
 
 
 
 
 
On September 10, 2010, Wells Fargo & Company filed an additional product supplement under its Medium-Term Note Program, Series K. The purpose of this Current Report is to file with the Securities and Exchange Commission the opinion of Sullivan & Cromwell LLP, Wells Fargo & Company's special tax counsel.
 
 
 
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
 
 
 
 

Exhibit 5.1
Wells Fargo & Company
420 Montgomery Street
San Francisco, California 94163
Wells Fargo Securities, LLC
550 California Street, 14th Floor
San Francisco, California 94104
Morgan Stanley & Co. Incorporated
1585 Broadway
New York, New York 10036
Ladies and Gentlemen:
We have acted as special tax counsel to Wells Fargo & Company, a Delaware corporation (the "Company"), in connection with the establishment of a series of securities designated as the Company's Medium-Term Notes, Series K, in an aggregate principal amount of $25,000,000,000 (the "Notes"). We hereby confirm our opinion as set forth under the heading "United States Federal Income Tax Considerations" in the following product supplement related to the Notes:
 
We hereby consent to the reference to us in the foregoing Product Supplement under the caption "United States Federal Income Tax Considerations" and the filing of this opinion as an exhibit to the Product Supplement. In giving such consent, we do not admit that we are within the category of persons whose consent is required under Section 7 of the Securities Act of 1933.
 


